The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of inactivation of PI3K/AKT/mTOR signaling pathway using neoadjuvant BKM120 in PI3KCA mutated early breast cancer.
Estevez G Laura
No relevant relationships to disclose
Suarez Ana
No relevant relationships to disclose
Calvo Isabel
No relevant relationships to disclose
Maria Fernandez Abad
No relevant relationships to disclose
Sofia Perea
No relevant relationships to disclose
Manuel Hidalgo
No relevant relationships to disclose